Health Service Modelling Associates (HSMAs) has been devised by NIHR PenCLAHRC at the University of Exeter Medical School to roll out a programme of training that uses computer modelling to help make difficult decisions. Read more.
University of Exeter, with support from Shell, has developed a method to make bacteria produce diesel on demand. The special strains of E. coli bacteria produces a fuel almost identical to conventional diesel. Read more.
Healthcare and Biotech
University of Exeter is a scientific hub for the region, open for collaboration, service work, facilities, consultancy and trialling interventions. Whether examining genetic pathways, creating diagnostic tools, performing health economics, assessments on environmental risk, or undertaking clinical trials for drugs or medical devices, the University strives to develop more strategic partnerships for specific indications and technologies across a number of business sectors, from biotechnology and public health, to nutraceuticals and sports performance, and food and drink.
We work with partners to provide solutions in diabetes, dementia, ageing, cardiovascular and metabolic disease, epigenetics, neurodegenerative disease, and mental health. We also deliver elite sports performance and product innovation, particularly in nutrition and wearables, along with exercise-related health interventions, environment and public health, bioinformatics and imaging.
We have invested heavily in cross-disciplinary translational bioscience, spearheaded by the new £52m Living Systems Institute and clinical studies within the Medical School. The School has award winning experts in diabetes and dementia and core research groups focused on ageing, cardiovascular and metabolic disease, epigenetics, neurodegenerative disease and mental health, as well as successful teams in environment and human health.
In our world leading Sports and Health Sciences department, we work with partners in elite performance and product innovation, particularly in nutrition and wearables and exercise-related health interventions across the lifespan.
Fundamental research is underpinned by a variety of cross cutting technologies and capabilities including bioinformatics, biomedical modelling, diagnostics and imaging; ultimately advancing towards clinical translation via an integrated and collaborative approach to influence policy change and achieve commercial impact.
Researchers and clinicians work together to ensure that research is targeted to clinical need; and applied health research links the needs of patients with those of health service providers. Our aim is to provide validated, improved treatments and a better quality of life for patients. It is typically developed in partnership with NHS and industry collaborators.
To discuss how we can work with you, please contact us.